Skip to content
10-Q

Quarterly Report

Advanced BioMedical Technologies, Inc.

0001493152-21-006507

← back to feed
Filed
Mar 22, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Mar 22, 2021 70.22M sh
Shares Diluted Q1 2021 · Jan 31, 2021 70.3M sh
Shares Diluted Q1 2021 · Jan 31, 2020 69.87M sh
Capex Q1 2021 · Jan 31, 2021 $18.19K
Operating Cash Flow Q1 2021 · Jan 31, 2021 −$514.82K
Cash And Equivalents Q1 2021 · Jan 31, 2021 $8.49K
Cash And Equivalents Q1 2021 · Oct 31, 2020 $201.66K
Stockholders Equity Q1 2021 · Jan 31, 2021 −$7.83M
Stockholders Equity Q1 2021 · Oct 31, 2020 −$7.4M
Current Liabilities Q1 2021 · Jan 31, 2021 $8.16M
Current Liabilities Q1 2021 · Oct 31, 2020 $7.86M
Current Assets Q1 2021 · Jan 31, 2021 $187.11K
Current Assets Q1 2021 · Oct 31, 2020 $330.95K
Total Assets Q1 2021 · Jan 31, 2021 $331.79K
Total Assets Q1 2021 · Oct 31, 2020 $469.23K
Sga Expense Q1 2021 · Jan 31, 2021 $38.65K
Rd Expense Q1 2021 · Jan 31, 2021 $66.81K
Net Income Q1 2021 · Jan 31, 2021 −$172.04K
Operating Income Q1 2021 · Jan 31, 2021 −$88.64K
Gross Profit Q1 2021 · Jan 31, 2021 $37.09K
Cost Of Revenue Q1 2021 · Jan 31, 2021 $10.15K
Revenue Q1 2021 · Jan 31, 2021 $47.23K